ORAL SMALL MOLECULES
Integrated endothelial restoration
Phenotype-led oral medicines for multifactorial vascular dysfunction.
Curacle proprietary · SOLVADYS®
Restoring Microvessels,
Redefining Health
Curacle develops first-in-class therapies restoring microvascular function
in aging
and chronic diseases.
OUR TECHNOLOGY
Two development engines.
One vascular strategy.
Curacle pairs phenotype-led oral medicines with vascular-targeted biologics to address complex endothelial dysfunction at complementary levels.
VASCULAR-TARGETED BIOLOGICS
Precision vascular signaling
Engineered antibody biologics for defined disease-driving pathways.
Co-developed with MabTics · EAGLES®-enabled
-
파이프라인 우선순위 및 개발전략 워크숍 진행
-
큐라클·맵틱스, AI 기반 혈관염 이중항체 'MT-501' 국가과제 선정
-
큐라클·맵틱스, ‘2026 글로벌 오픈이노베이션 위크’ 참가해 파트너링 미팅 진행